CANbridge Pharmaceuticals Inc. (HKG:1228)

CANbridge Pharmaceuticals Statistics

Total Valuation

HKG:1228 has a market cap or net worth of HKD 1.08 billion. The enterprise value is 1.02 billion.

Market Cap	1.08B
Enterprise Value	1.02B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1228 has 595.44 million shares outstanding. The number of shares has increased by 7.60% in one year.

Current Share Class	595.44M
Shares Outstanding	595.44M
Shares Change (YoY)	+7.60%
Shares Change (QoQ)	+15.19%
Owned by Insiders (%)	7.15%
Owned by Institutions (%)	11.89%
Float	338.30M

Valuation Ratios

The trailing PE ratio is 54.22.

PE Ratio	54.22
Forward PE	n/a
PS Ratio	19.38
PB Ratio	-2.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	61.95
EV / Sales	18.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.02

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.42
Interest Coverage	-41.22

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-40.72%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	31.70%
Weighted Average Cost of Capital (WACC)	4.05%
Revenue Per Employee	1.36M
Profits Per Employee	402,186
Employee Count	45
Asset Turnover	0.35
Inventory Turnover	0.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1,174.81% in the last 52 weeks. The beta is -0.06, so HKG:1228's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	+1,174.81%
50-Day Moving Average	2.39
200-Day Moving Average	2.33
Relative Strength Index (RSI)	23.23
Average Volume (20 Days)	914,089

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1228 had revenue of HKD 55.62 million and earned 16.49 million in profits. Earnings per share was 0.03.

Revenue	55.62M
Gross Profit	41.54M
Operating Income	-102.30M
Pretax Income	16.49M
Net Income	16.49M
EBITDA	-90.13M
EBIT	-102.30M
Earnings Per Share (EPS)	0.03

Balance Sheet

The company has 74.14 million in cash and 17.90 million in debt, with a net cash position of 56.24 million or 0.09 per share.

Cash & Cash Equivalents	74.14M
Total Debt	17.90M
Net Cash	56.24M
Net Cash Per Share	0.09
Equity (Book Value)	-380.31M
Book Value Per Share	-0.74
Working Capital	-384.11M

Cash Flow

In the last 12 months, operating cash flow was -42.52 million and capital expenditures -6,677, giving a free cash flow of -42.53 million.

Operating Cash Flow	-42.52M
Capital Expenditures	-6,677
Depreciation & Amortization	12.63M
Net Borrowing	-21.04M
Free Cash Flow	-42.53M
FCF Per Share	-0.07

Margins

Gross margin is 74.68%, with operating and profit margins of -183.92% and 29.65%.

Gross Margin	74.68%
Operating Margin	-183.92%
Pretax Margin	29.65%
Profit Margin	29.65%
EBITDA Margin	-162.05%
EBIT Margin	-183.92%
FCF Margin	n/a

Dividends & Yields

HKG:1228 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.60%
Shareholder Yield	-7.60%
Earnings Yield	1.53%
FCF Yield	-3.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1228 has an Altman Z-Score of -38.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-38.93
Piotroski F-Score	4